Reassuringly, GVT responses using AMPK-KO T cells were equivalent to WT T cells over a wide (10-fold) range of donor T cell doses, suggesting that even at very low numbers, T cells lacking AMPK exert leukemia control that is equivalent to WT cells. The gene discussed is PRKAA1; the disease is leukemia.